BridgeMD
Efficacy of sufentanil in urgent laparoscopic cholecystectomy: An alternative to the usual opioids for postoperative pain?
EU CTIS ID: 2026-525783-18-00
What this study is testing
Determine whether intraoperative administration of sufentanil using concentration-targeted continuous intravenous infusion (TCI) models is not inferior to postoperative analgesia within 24 hours after surgery (measured by EVA) in patients undergoing urgent laparoscopic cholecystectomy, compared to the administration of fentanyl according to standard clinical practice at our hospital.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age equal to or older than 18 years.
- ASA Classification I, II or III.
- Urgent laparoscopic cholecystectomy surgery.
- Signing the Informed Consent.
You likely can't join if
- Known allergy to Fentanyl or Sufentanil.
- ASA IV or V
- Chronic opioid use, oral morphine equivalent dose >10 DEM.
- Psychiatric or neurological pathology that prevents collaboration or use of the EVA scale.
- Severe kidney or liver failure.
- Moderate pulmonary pathology or home oxygen.
See the full eligibility criteria
- Age equal to or older than 18 years.
- ASA Classification I, II or III.
- Urgent laparoscopic cholecystectomy surgery.
- Signing the Informed Consent.
- Known allergy to Fentanyl or Sufentanil.
- ASA IV or V
- Chronic opioid use, oral morphine equivalent dose >10 DEM.
- Psychiatric or neurological pathology that prevents collaboration or use of the EVA scale.
- Severe kidney or liver failure.
- Moderate pulmonary pathology or home oxygen.
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.